Literature DB >> 20425545

Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis.

Kei Miyoshi1, Takeshi Mimura, Koichiro Iwanaga, Shuji Adachi, Noriaki Tsubota, Morihito Okada.   

Abstract

PURPOSE: The preoperative assessment of nodal status in lung cancer is complicated and problematic for physicians and surgeons. Although many patients with clinical N1 (cN1) non-small cell lung cancer (NSCLC) are candidates for surgical treatment, these patients represent a heterogeneous subgroup with unpredictable survival. We conducted this study to evaluate the surgical results of cN1 disease and to attempt to clarify the delicate issues surrounding its diagnosis and prognosis.
METHODS: The subjects of this study were 187 consecutive patients with cN1 adenocarcinoma or squamous cell carcinoma of the lung, who underwent complete resection without induction therapy.
RESULTS: Only 25% of the adenocarcinomas and 54% of the squamous cell carcinomas were correctly diagnosed as N1 disease preoperatively. Multiple logistic regression analyses revealed that adenocarcinoma (P = 0.0141) was a significant predictor of pN2. Multivariate analyses revealed that nodal metastasis (P < 0.0001), large tumor size (P = 0.0079), and high serum carcinoembryonic antigen value (P = 0.0096) were significantly poor prognostic factors in cN1 patients.
CONCLUSIONS: It is difficult to diagnose nodal status in patients with cN1 disease, which requires various surgical procedures, including plasty, possibly with adjuvant therapy in a defined high-risk subgroup.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425545     DOI: 10.1007/s00595-008-4072-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy.

Authors:  M Okada; H Yamagishi; S Satake; H Matsuoka; Y Miyamoto; M Yoshimura; N Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2000-04       Impact factor: 5.209

2.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

3.  Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.

Authors:  Toshio Fujimoto; Stephen D Cassivi; Ping Yang; Sunni A Barnes; Francis C Nichols; Claude Deschamps; Mark S Allen; Peter C Pairolero
Journal:  J Thorac Cardiovasc Surg       Date:  2006-07-28       Impact factor: 5.209

4.  Mediastinal lymph node size in lung cancer.

Authors:  H I Libshitz; R J McKenna
Journal:  AJR Am J Roentgenol       Date:  1984-10       Impact factor: 3.959

5.  Prospective study of 445 lung carcinomas with mediastinal lymph node metastases.

Authors:  N Martini; B J Flehinger; M B Zaman; E J Beattie
Journal:  J Thorac Cardiovasc Surg       Date:  1980-09       Impact factor: 5.209

6.  Lymph node mapping and curability at various levels of metastasis in resected lung cancer.

Authors:  T Naruke; K Suemasu; S Ishikawa
Journal:  J Thorac Cardiovasc Surg       Date:  1978-12       Impact factor: 5.209

7.  Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.

Authors:  Shun-ichi Watanabe; Hisao Asamura; Kenji Suzuki; Ryosuke Tsuchiya
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

8.  Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.

Authors:  Morihito Okada; Toshihiko Sakamoto; Wataru Nishio; Kazuya Uchino; Noriaki Tsubota
Journal:  Cancer       Date:  2003-08-01       Impact factor: 6.860

9.  Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Tsuyoshi Yuki; Akio Nakagawa; Noriaki Tsubota
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

10.  Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer.

Authors:  Takeshi Hanagiri; Kenji Sugio; Hidetaka Uramoto; Tetsuya So; Yoshinobu Ichiki; Masakazu Sugaya; Kenji Ono; Manabu Yasuda; Tadahiro Nozoe; Kosei Yasumoto
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.540

View more
  9 in total

1.  Histological type predicts mediastinal metastasis and surgical outcome in resected cN1 non-small cell lung cancer.

Authors:  Tetsuya Mizuno; Takaaki Arimura; Hiroaki Kuroda; Noriaki Sakakura; Yasushi Yatabe; Yukinori Sakao
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-06-28

2.  Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer.

Authors:  John C Haney; Jennifer M Hanna; Mark F Berry; David H Harpole; Thomas A D'Amico; Betty C Tong; Mark W Onaitis
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-02       Impact factor: 5.209

3.  Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer.

Authors:  Masaya Tamura; Isao Matsumoto; Yusuke Tanaka; Daisuke Saito; Shuhei Yoshida; Munehisa Takata; Hirofumi Takemura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-18

4.  Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.

Authors:  Takayuki Fukui; Katsuhiko Kato; Toshiki Okasaka; Koji Kawaguchi; Koichi Fukumoto; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-09-02

Review 5.  Diagnostic imaging in the preoperative management of lung cancer.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Hajime Saito; Satoru Motoyama; Yusuke Sato; Aki Ito; Kei Yoshino; Satoshi Kudo; Shinogu Takashima; Yasushi Kawaharada; Nobuyasu Kurihara; Kimito Orino; Jun-Ichi Ogawa
Journal:  Surg Today       Date:  2013-07-10       Impact factor: 2.549

6.  The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer.

Authors:  Sirisha Jonnalagadda; Cardinale Smith; Grace Mhango; Juan P Wisnivesky
Journal:  Chest       Date:  2011-02-03       Impact factor: 9.410

7.  Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines.

Authors:  Dongsheng Yue; Liqun Gong; Jian You; Yanjun Su; Zhenfa Zhang; Zhen Zhang; Feng Gu; Meng Wang; Changli Wang
Journal:  BMC Cancer       Date:  2014-06-10       Impact factor: 4.430

8.  Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.

Authors:  Masato Aragaki; Tatsuya Kato; Aki Fujiwara-Kuroda; Yasuhiro Hida; Kichizo Kaga; Satoru Wakasa
Journal:  J Cardiothorac Surg       Date:  2020-08-28       Impact factor: 1.637

9.  New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB-III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes.

Authors:  Komei Kameyama; Kazuhiro Imai; Koichi Ishiyama; Shinogu Takashima; Shoji Kuriyama; Maiko Atari; Yoshiaki Ishii; Akihito Kobayashi; Shugo Takahashi; Mirai Kobayashi; Yuzu Harata; Yusuke Sato; Satoru Motoyama; Manabu Hashimoto; Kyoko Nomura; Yoshihiro Minamiya
Journal:  Thorac Cancer       Date:  2022-01-20       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.